Dr Suzanne Kc Benser, MD | |
555 E City Ave Ste 400, Bala Cynwyd, PA 19004-1112 | |
(610) 668-2188 | |
Not Available |
Full Name | Dr Suzanne Kc Benser |
---|---|
Gender | Female |
Speciality | Psychiatry |
Experience | 36 Years |
Location | 555 E City Ave Ste 400, Bala Cynwyd, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154536035 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD0424730 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Suzanne Kc Benser, MD 555 E City Ave Ste 400, Bala Cynwyd, PA 19004-1112 Ph: (610) 668-2188 | Dr Suzanne Kc Benser, MD 555 E City Ave Ste 400, Bala Cynwyd, PA 19004-1112 Ph: (610) 668-2188 |
News Archive
Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.
Is heading straight for a goal the quickest way there? If the name of the game is evolution, suggests new research at the Weizmann Institute of Science, the pace might speed up if the goals themselves change continuously.
Studies have well established that women who harbor a mutation in the BRCA1 tumor suppressor gene are at greater risk for developing breast and ovarian cancers. Less known is information on other molecular events that may impact cancer formation in cells having a BRCA1 mutation. Investigators from The Cancer Institute of New Jersey and a number of major cancer centers in Europe have identified the role a key protein plays in helping cells with mutant BRCA1 genes to survive.
The percentage of women and girls in Nicaragua's second-largest city who reported experiencing physical violence by their partners during their lifetimes decreased from 55% in 1995 to 28% in 2016, according to a new study published in the journal BMJ Global Health.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy.
› Verified 5 days ago
Dr. Richard B Cornfield, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 29 Bala Ave, Suite 222, Bala Cynwyd, PA 19004 Phone: 610-864-5512 Fax: 484-270-8332 | |
Donald N Tavakoli, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 191 Presidential Blvd, Suite C132, Bala Cynwyd, PA 19004 Phone: 610-664-5182 | |
Dr. Ira Brenner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 Presidential Blvd, Suite 116, Bala Cynwyd, PA 19004 Phone: 610-667-3183 Fax: 610-667-4401 | |
Arnold Charles Winkelman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 724 Oxford Rd, Bala Cynwyd, PA 19004 Phone: 610-724-2337 | |
Dr. Sondra L Corgan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 333 E City Ave Ste Pl13, Bala Cynwyd, PA 19004 Phone: 267-225-1745 Fax: 973-440-3267 | |
Tal E Weinberger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 29 Bala Ave, Suite 224, Bala Cynwyd, PA 19004 Phone: 610-668-1492 |